Inhibitor cross-reactivity with human fVIII and hybrid fVIII constructs or porcine fVIII.

Inhibitor activity was measured by the Bethesda assay as described in “Materials and Methods.” Cross-reactivity is expressed as the percentage Bethesda titer relative to human B-domainless fVIII.